Your browser doesn't support javascript.
loading
Artificial Macrocycles as Potent p53-MDM2 Inhibitors.
Estrada-Ortiz, Natalia; Neochoritis, Constantinos G; Twarda-Clapa, Aleksandra; Musielak, Bogdan; Holak, Tad A; Dömling, Alexander.
Afiliação
  • Estrada-Ortiz N; Department of Drug Design, University of Groningen, A. Deusinglaan 1, Groningen 9700AV, The Netherlands.
  • Neochoritis CG; Department of Drug Design, University of Groningen, A. Deusinglaan 1, Groningen 9700AV, The Netherlands.
  • Twarda-Clapa A; Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, Gronostajowa 7, 30-387 Krakow, Poland.
  • Musielak B; Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387 Krakow, Poland.
  • Holak TA; Department of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Krakow, Poland.
  • Dömling A; Malopolska Centre of Biotechnology, Jagiellonian University, Gronostajowa 7a, 30-387 Krakow, Poland.
ACS Med Chem Lett ; 8(10): 1025-1030, 2017 Oct 12.
Article em En | MEDLINE | ID: mdl-29057045
Based on a combination of an Ugi four component reaction and a ring closing metathesis, a library of novel artificial macrocyclic inhibitors of the p53-MDM2 interaction was designed and synthesized. These macrocycles, alternatively to stapled peptides, target for the first time the large hydrophobic surface area formed by Tyr67, Gln72, His73, Val93, and Lys94 yielding derivatives with affinity to MDM2 in the nanomolar range. Their binding affinity with MDM2 was evaluated using fluorescence polarization (FP) assay and 1H-15N two-dimensional HSQC nuclear magnetic resonance experiments.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article